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TRPM7 is a ubiquitous ion channel and kinase, a
unique ‘‘chanzyme,’’ required for proper early embry-
onic development. It conducts Zn2+, Mg2+, and Ca2+
as well as monovalent cations and contains a func-
tional serine/threonine kinase at its carboxyl termi-
nus. Here, we show that in normal tissues and cell
lines, the kinase is proteolytically cleaved from the
channel domain in a cell-type-specific manner.
These TRPM7 cleaved kinase fragments (M7CKs)
translocate to the nucleus and bind multiple com-
ponents of chromatin-remodeling complexes, in-
cluding Polycomb group proteins. In the nucleus,
the kinase phosphorylates specific serines/threo-
nines of histones. M7CK-dependent phosphoryla-
tion of H3Ser10 at promoters of TRPM7-dependent
genes correlates with their activity. We also demon-
strate that cytosolic free [Zn2+] is TRPM7 dependent
and regulates M7CK binding to transcription factors
containing zinc-finger domains. These findings sug-
gest that TRPM7-mediated modulation of intra-
cellular Zn2+ concentration couples ion-channel
signaling to epigenetic chromatin covalent modifica-
tions that affect gene expression patterns.INTRODUCTION
TRPM7 is a ubiquitously expressed cationic ion channel and
serine/threonine kinase (Nadler et al., 2001; Runnels et al.,
2001; Yamaguchi et al., 2001). Global disruption of Trpm7 in
mice results in embryonic lethality before embryonic day 7 (E7)
(Jin et al., 2008). Tissue-specific reduction of TRPM7 gene
expression between E7 and E12 of development results in
abnormalities of multiple organs (Jin et al., 2012). TRPM7-defi-
cient thymocytes exhibit dysregulated synthesis of many growth
factors that are necessary for the differentiation and main-
tenance of thymic epithelial cells (Jin et al., 2008). Loss of
TRPM7 at an intermediate developmental time point alters the
myocardial transcriptional profile in adulthood, impairing ventric-
ular function (Sah et al., 2013). TRPM7 overexpression in human
embryonic kidney cells alters the transcriptional profile of hun-dreds genes (Lee et al., 2011). These data indicate that TRPM7
is intimately associated with developmental, tissue-specific
regulation of gene activity. We set out to determine how
TRPM7’s channel or kinase function has such broad, tissue-
specific, and age-dependent effects on gene activity.
Initially, TRPM7 was thought to mediate cellular Mg2+ homeo-
stasis based on growth arrest in TRPM7-deficient DT-40 B cells:
growth arrest could be restored by culturing these cells in media
supplemented with high Mg2+ (Nadler et al., 2001; Schmitz et al.,
2003, 2005). In other cell types, however, loss of TRPM7 expres-
sion resulted in defects in cell growth that could not be rescued
by excess Mg2+ (Hanano et al., 2004) or that even promoted
proliferation (Inoue and Xiong, 2009). In addition, TRPM7 was
not essential for proliferation and maintenance of Mg2+ levels
in thymocytes derived from mice with a tissue-targeted TrpM7
deletion (Jin et al., 2008). In some cases, TRPM7 appears to
modulate Ca2+ signaling (Du et al., 2010; Hanano et al., 2004;
Middelbeek et al., 2012). Thus, the consequences of TRPM7’s
channel function are not settled; it may vary by tissue type
and/or by its relative localization and gating in the cell’s plasma
or intracellular membranes.
TRPM7’s most unique aspect is its C-terminal active serine/
threonine kinase. The functional significance of this coupling of
channel and kinase is not clear. Aside from the hypothesis that
channel-dependent changes in cytosolic Mg2+ may control the
activity of the kinase (Schmitz et al., 2003), no experimental
data suggest that kinase activity is channel dependent. In turn,
kinase activity is not essential for channel gating (Clark et al.,
2006; Matsushita et al., 2005), although it may modulate channel
activity (Demeuse et al., 2006; Desai et al., 2012; Schmitz et al.,
2003). Although TRPM7 kinase activity may be controlled
through the autophosphorylation of a serine/threonine-rich
region located N terminal to the catalytic domain (Clark et al.,
2008b), external signals regulating the kinase activity are not
known. In vitro substrates for the TRPM7 kinase, annexin A1
(Dorovkov and Ryazanov, 2004) and myosin IIA heavy chain
(Clark et al., 2008a), are not necessarily substrates in vivo.
More recently, the TRPM7 kinase was proposed to regulate
phosphorylation of eukaryotic elongation factor 2 (eEF2) via acti-
vation of the eEF2-kinase (Perraud et al., 2011).
Here, we show that in many cell lines and normal tissues,
TRPM7’s kinase is released from the channel domain in a
cell-type-specific fashion. TRPM7 cleaved kinases (M7CKs)
translocate to the nucleus and bind multiple components of
chromatin-remodeling complexes, including Polycomb groupCell 157, 1061–1072, May 22, 2014 ª2014 Elsevier Inc. 1061
Figure 1. TRPM7 Cleavage Fragments Identified in Multiple Cell
Lines and Tissues
(A) TRPM7 protein cleavage fragments in mouse mesangial SV40 mes13 cells.
Cells were extracted with Tris-buffered saline (TBS)/1% NP40. Endogenous
TRPM7 was immunoprecipitated (IP’d) from lysates with TRPM7 C-terminal
mouse monoclonal antibody (aA25) or normal mouse immunoglobulin G (IgG)
and probed on western blots (WBs) with anti-C-terminal rabbit antibody
(aC47). C-terminally HA-tagged TRPM7 (expressed = expr) was IP’d with anti-
HA-agarose (aHA) from SV40 mes13 cells stably expressing recombinant
protein and probed on WBs with aHA-peroxidase conjugate. Scale (left) in-
dicates the molecular weight of major bands calculated from their electro-
phoreticmobility relative to standardmolecular weight markers. Cartoon (right)
shows the approximate position of cleavage sites; K indicates kinase domain.
(B) TRPM7 cleavage pattern in eight distinct cell lines. Mouse mesangial (SV40
mes13), macrophage (RAW 264.7), mESC, human B-lymphocyte (Raji),
Caco-2 (colon epithelial), prostate (metastatic LNCaP and nonmetastatic
RWPE1), and human embryonic kidney 293 (HEK293) cells were extracted and
IP’d as described in (A). Extracts demonstrate the relative amounts of cleaved
TRPM7 isolated from each tissue. Information about the relative content of the
full-length TRPM7 and the cleaved fragments is contained in each individual
lane, which is intentionally not normalized to control protein. No positive bands
were found from the same tissue extracts IP’d with normal mouse IgG (data not
shown). mESCs were generated as described in Experimental Procedures
from WT or TrpM7/ (KO) blastocysts. The lower panel in the mESC column
shows equal actin content in bothmESC lysates. Samples run on different gels
are combined in the figure and aligned against identical molecular weight
markers.
(C) TRPM7 cleavage pattern in different mouse tissues. Freshly isolatedmouse
organs were extracted and IP’d as described in (A). Extracts demonstrate the
relative amounts of cleaved TRPM7 isolated from in each tissue. No positive
bands were found from the same tissue extracts IP’d with normal mouse IgG
(data not shown).
See also Figures S1, S2, and S4.
1062 Cell 157, 1061–1072, May 22, 2014 ª2014 Elsevier Inc.proteins. In the nucleus, TRPM7’s kinase modifies specific his-
tone phosphorylation, particularly in the promoters of TRPM7-
dependent genes. We show that cytosolic free zinc levels are
TRPM7 dependent and regulate M7CK binding to transcription
factors containing zinc-binding domains. We hypothesize that
TRPM7-mediated increases in cytoplasmic zinc couples chan-
nel function to chromatin covalent modification and thus affects
cellular differentiation and embryonic development.
RESULTS
The TRPM7 Kinase Is Proteolytically Cleaved from the
Channel Domain In Vivo
Although ubiquitously expressed, TRPM7 protein is of low abun-
dance. In order to detect endogenous protein expression, we
isolated the protein from large numbers of cells using a mouse
antibody for immunoprecipitation (IP) followed by western blot
(WB) with rabbit antibodies to avoid antibody cross-reaction. In
the course of these experiments, we noticed that in addition to
a 210 kDa band corresponding to full-length TRPM7, several
lower-molecular-weight bands were consistently detected (Fig-
ure 1A). This finding suggested that the endogenous TRPM7
molecule is proteolytically cleaved at specific sites. We refer to
these fragments as TRPM7-cleaved kinases (M7CKs). Because
both antibodies recognize the TRPM7 C terminus, the major
bands corresponded to TRPM7 fragments that were cleaved
between the transmembrane and kinase domains. These frag-
ments were not the result of proteolysis during IP because their
relative abundance did not vary with time over 2–17 hr (Fig-
ure S1A available online). It is unlikely that these bands belong
to proteins unrelated to TRPM7, because they were sequentially
recognized with two different TRPM7 antibodies used for IP and
WB. Yet, to rule out this possibility, we stably expressed C-termi-
nally hemagglutinin (HA)-tagged TRPM7 and used the well-char-
acterized anti-HA-tag antibody (aHA) for IP and WB. Figure 1A
shows that the ectopically expressed TRPM7-HA yielded major
fragments identical to those for endogenous TRPM7 as well as a
few minor lower-molecular-weight fragments that may have
resulted from elevated protein expression. Because TRPM7-
HAwas ectopically expressed, this result obviates the possibility
that C-terminal TRPM7 fragments were products of alternative
RNA splicing. The fragments could have been generated from
M7CK translation from multiple internal ribosome entry sites
(IRESs) present on its C terminus or specific posttranslational
proteolytic cleavage. However, IRES-dependent translation is
unlikely, because among more then 100 eukaryotic cellular
mRNAs proposed to contain IRESs, few have putative IRES
sequences within exons (Thompson, 2012; see also http://
iresite.org). Moreover, there were no confirmed multiple IRESs
within one mRNA. Thus, it is most likely that a proteolytic mech-
anism underlies the C-terminal fragment formation, as we previ-
ously demonstrated for caspase-mediated TRPM7 cleavage
(Desai et al., 2012). Thus, a substantial fraction of TRPM7 is
cleaved in specific positions of the TRPM7 C terminus, liberating
the protein kinase from the channel domain.
Different cell types display specific TRPM7 cleavage patterns
seen as differences in relative expression ofmajor fragments and
generation of unique fragments (Figure 1B). This suggests there
are cell-type-specificmechanisms defining the cleavage site and
potentially distinct functions for each cleaved fragment. This
hypothesis is consistent with the observation that the TRPM7
cleavage pattern changes during differentiation ofmouse embry-
onic stem cells (mESCs) into specific progenitors (Figure S1).
Upon differentiation into embryoid bodies, distinct C-terminal
cleaved fragments transiently appeared on days 8–12 of differ-
entiation (Figure S1B). Neuronal progenitors derived from
mESCs lack the 65 kDa C-terminal fragment detected in mESCs
and display only full-length TRPM7 protein (Figure S1C). Animal
tissues also display a diversity of TRPM7 cleavage patterns (Fig-
ure 1C) more complex than those observed in cell lines, presum-
ably because each tissue is composed of many cell types.
Because a substantial proportion of TRPM7 protein was found
as C-terminal fragments in many different cell types (e.g., 50%–
70% in SV40 mes13 cells and close to 100% in mouse kidney),
weexpected to findequivalent amounts of the truncatedchannel.
Thus, we immunoprecipitated TRPM7 with antibody recognizing
the N-terminal epitope (NFP, amino acids 532–620) and western
blotted with a C-terminal antibody (aCFP, amino acids
1,277–1,380) recognizing an epitope situated upstream of the
C-terminal cleavage sites. This antibody combination reliably
recognized transiently expressed recombinant full-length or trun-
cated TRPM7aswell as endogenous full-length protein but failed
to detect endogenous truncated channels (Figure S1D). The lack
of channel-domain-containing protein suggests that the trun-
cated channel was eliminated after C-terminal cleavage. This is
consistent with results obtained using genetically modified
mESCs that produce a TRPM7 RNA with the stop codon placed
in front of kinase domain (halting translation after amino acid
1,537; Ryazanova et al., 2010). Patch-clamp measurements of
these cells failed to detect the characteristic TRPM7 current
(Ryazanova et al., 2010). Our antibody combination readily de-
tected the full-length channel in WT mESCs and the caspase-
cleaved endogenous channel (Desai et al., 2012), but not the
truncated channel, in D-kinase mESCs (Figure S1E). These data
suggest that C-terminally truncated TRPM7 protein containing
thechannel domain is normally eliminated fromproliferating cells.
M7CK Binds Multiple Components of Chromatin-
Remodeling Complexes
In previous experiments (Krapivinsky et al., 2006), we identified
proteins that interact with TRPM7 using yeast two-hybrid
screening. Evolutionarily conserved protein fragments of the
humanTRPM7N-andC-terminal cytoplasmicdomainswerecho-
senasbaits.Screeningof a humanbrain librarywithabait contain-
ingaportionof theTRPM7Cterminus (aminoacids1,364–1,865of
NP_060142.3) revealed the Ring1 and YY1 binding protein, RYBP
(NP_036366.3), asapotential TRPM7 interactor.BecauseRYBP is
a transcription factor strictly confined to the nucleus (Garcı´a et al.,
1999) and the TRPM7 channel is a plasma membrane and vesic-
ular protein, we assumed that it was a false positive. However,
when we performed tandem affinity purification of the same
TRPM7 fragment stably expressed in SV40mes13 cells, we iden-
tifiedanumberofnuclearproteins thatcopurifiedwithTRPM7 (see
Table S1). Given that portions of the TRPM7 C terminus are natu-
rally cleaved from the channel and located in the nucleus (shown
in Figure 3), we set out to investigate these potential interactions.In order to verify endogenous M7CK-interacting proteins, we
generated mESCs lacking TrpM7 (TrpM7/; see Experimental
Procedures, Figure 1B, and Figure S2) and used these cells
as negative controls in coimmunoprecipitation experiments.
TRPM7 IP from mESCs confirmed binding of endogenous
TRPM7 with the nuclear proteins RYBP, Ruvbl1/pontin,
Ruvbl2/reptin, DDX3X, DDB1, and DBC1 (Figure 2A; Figure S3),
all constituents of chromatin-remodeling complexes (see Table
S2 for annotation of these proteins). RYBP is a component of
Polycomb repressor complex 1 (PRC1) and also interacts with
the transcription factor YY1 (Garcı´a et al., 1999; Tavares et al.,
2012). YY1 is part of the PRC2 histone methylation complex
(Satijn et al., 2001) and the INO80 chromatin-remodeling
complex (Cai et al., 2007; Wu et al., 2007). The RNA helicase
DDX3X and the DNA helicases pontin and reptin are also com-
ponents of the INO80 complex (Vella et al., 2012; Huen et al.,
2010) and of the histone deacetylase (Gallant, 2007) and b-cate-
nin (Bauer et al., 2000; Kim et al., 2005; Sierra et al., 2006) com-
plexes. DDB1 is the core component of the Cul4 ubiquitin ligase
complex participating in DNA-damage-activated chromatin
modification (Higa et al., 2006; Iovine et al., 2011). Finally,
DBC1 is an inhibitor of the histone deacetylases Sirt1 (Zhao
et al., 2008) and HDAC3 (Chini et al., 2010). Figure 2A and Fig-
ure S3B show that endogenous TRPM7 specifically binds core
PRC1 protein RNF2, core PRC2 proteins Ezh2 and EED1,
INO80DNA helicase, YY1, b-catenin, and DDB1, but not HDAC1.
To verify that M7CK fragments of TRPM7 bind all these
molecules, we made constructs expressing portions of the
TRPM7 C terminus. Because we do not know the precise
cleavage sites for endogenous TRPM7, we made a series of
constructs that would express fragments of the C terminus
with molecular masses close to those of major M7CKs, as
calculated from their electrophoretic mobilities. Proteins con-
taining mouse TRPM7 amino acids 1,299–1,863, 1,397–1,863,
and 1,445–1,863 (all three contain the full kinase domain)
most precisely comigrate with endogenous cleaved TRPM7
kinase (Figure S3A). We refer to these proteins as M7CK-
Long, M7CK-Medium, and M7CK-Short, respectively. We
tagged these proteins on their C termini with an HA epitope
tag and tested their ability to bind TRPM7-interacting proteins.
Figure 2B shows that proteins that bound endogenous TRPM7
are specifically coimmunoprecipitated with M7CKs when
coexpressed in 293T cells (see also Figures S3B–S3E demon-
strating binding of M7CK to Cul4, DBC1, and Sirt1). This result
indicates that the binding site for the nuclear proteins is located
on the M7CK portion of TRPM7’s C terminus. Note that there
are differences in the binding of nuclear proteins to the cleaved
kinases; Ezh2 and YY1 bind all three cleaved kinases, while
RYBP, EED, RNF2, and DDX3X do not bind M7CK-S. RING1A
binds only M7CK-M, and INO80 binds only M7CK-L. This
pattern of selective binding may rationalize the existence of
multiple M7CKs in different cell types (Figure 1B).
To test for direct M7CK binding to interacting molecules, we
affinity-purified HA-tagged M7CK-L produced in E. coli (Fig-
ure S3F). Purified M7CK was combined with purified recombi-
nant YY1 or the Ezh2-EED-Suz12 complex and pulled down
with aHA agarose. As shown on Coomassie-stained gels (Fig-
ure 2C), both YY1 and the Ezh2 complex specifically boundCell 157, 1061–1072, May 22, 2014 ª2014 Elsevier Inc. 1063
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Figure 2. TRPM7 Binds Transcription
Factors and Subunits of Chromatin-Remod-
eling Complexes
(A) Endogenous TRPM7 was IP’d from combined
cytosolic plus nuclear extracts of WT or KO9
mESCs with aA25 mouse or aC47 rabbit antibody
and the IP probed on WBs with antibody to the
indicated proteins. INO80 cell lysate lanes were
run on a different gel, as indicated by the gap.
(B) Subunits of Polycomb and INO80 chromatin-
remodeling complexes bind ectopically expressed
M7CKs. FLAG-tagged transcription factors were
transiently coexpressed in 293T cells with HA-
tagged M7CK-L, M7CK-M, or M7CK-S. Cytosolic
plus nuclear extract was IP’d with aHA-agarose,
and co-IP’d proteins were probed on WBs with
aFLAG-peroxidase.
(C) The affinity-purified long form of M7CK
(M7CK-L) binds purified transcription factors
(Coomassie). Left three panels: HA-tagged
M7CK-L (M7) was combined with purified YY1 or
Ezh2 protein complexes and IP’d with aHA-
agarose. Right: purified GST or GST-RYBP frag-
ment (M7CK-binding domain, amino acids 22–47;
GST-RYBPbd) fusion proteins were combined with
purified M7CK-L and GST pulled down with
glutathione agarose.
See also Figures S2 and S3.M7CK. The TRPM7-binding domain of RYBP (amino acids 22–
47, zinc-finger domain) expressed as a glutathione S-transferase
(GST) fusion protein and purified from E. coli directly bound
purified M7CK-L (Figure 2C). In summary, TRPM7’s cleaved
kinase fragments directly bind several components of the chro-
matin-remodeling complexes PRC1, PRC2, and INO80.
Nuclear Location of M7CK
Strikingly, abundant ectopically expressed TRPM7 C-terminal
fragments were found in cell nuclei (Figure 3). Analysis of the
TRPM7 amino acid sequences (http://nls-mapper.iab.keio.ac.
jp/cgi-bin/NLS_Mapper_form.cgi) predicted a putative nuclear
localization signal on the kinase C terminus (mTRPM7 amino
acids 1,780–1,807) that may provide the basis for importin-medi-
ated M7CK nuclear localization. Additionally, nuclear proteins
bound to M7CK could facilitate its translocation from cytosol
to nucleus or retain M7CK in the nucleus; both mechanisms
would increase nuclear M7CK. To determine whether M7CK-
binding nuclear proteins affect M7CK nuclear abundance, cells
were cotransfected with HA-tagged M7CK- and FLAG-tagged
nuclear binding proteins (RYBP or RNF2) or empty vector as
control. After cell fixation and immunostaining, relative nuclear
and cytosolic M7CK was quantified in confocal images. As
shown in Figure 3B, M7CK coexpression with nuclear-localized
interactors substantially increased the relative nuclear concen-
tration of M7CKs.1064 Cell 157, 1061–1072, May 22, 2014 ª2014 Elsevier Inc.Regulation of M7CK Binding
The preceding experiment suggests that
M7CKs can be targeted to a particular
nuclear protein by cleavage at a specificC-terminal site (Figure 2B). One obvious possibility is that
TRPM7’s channel activity regulates M7CK’s cleavage from the
channel domain. We compared the cleavage pattern of
expressed WT TRPM7 and a nonconducting pore mutant
that acts as a dominant negative (inhibits the conductance
of the native channel; Krapivinsky et al., 2006). Figure S4
shows that the cleavage pattern and extent of cleavage were
identical. These data suggest that the TRPM7 C-terminal
cleavage did not depend on a functional, ion-conducting pore.
This implies that ions entering via the channel pore are not
required to activate, for example, a localized protease that
cleaves TRPM7’s channel domain from its C-terminal-containing
kinase domain.
Another simple hypothesis is that TRPM7’s kinase ‘‘tags’’
itself via autophosphorylation for nuclear targeting. We thus
tested whether M7CK’s kinase activity is required for
nuclear protein binding. Point mutations in TRPM7’s kinase
ATP-binding site (K1646A) eliminated kinase activity as
detected by TRPM7 autophosphorylation (kinase-dead; Mat-
sushita et al., 2005; Figure S3G). These mutations had am-
biguous effects on the binding of target molecules. The
kinase-dead mutations did not affect Ezh2 binding but attenu-
ated YY1 and RYBP binding and enhanced RNF2 binding
(Figure S3H). Thus, regulation of TRPM7 kinase activity is a
potential mechanism for targeting M7CK to different nuclear
complexes.
Figure 3. Nuclear Location of M7CK
(A) TRPM7 cleavage fragments (M7CK) in the
nucleus and cytosol. HA-tagged TRPM7 C-termi-
nal fragment (amino acids 1,299–1,864; green)
expressed transiently (HEK) or stably (SV40
mes13) immunostained with aHA. Nuclei were
stained with propidium iodide (red).
(B) Bound nuclear proteins enable M7CK nuclear
accumulation. HEK cells were cotransfected with
the indicated HA-tagged M7CK and FLAG-tagged
nuclear protein or empty vector. Relative nuclear
and cytosolic M7CK concentration was measured
as average fluorescence intensity in confocal im-
ages of formaldehyde-fixed cells immunostained
with epitope-tagged antibodies; 60–70 cells were
measured for each condition. Cumulative fre-
quency plots demonstrate that coexpression with
the bound nuclear protein increases the fraction of
the cells with higher nuclear M7CK concentration.
p, Kolmogorov-Smirnov probability.TRPM7 is permeant to divalent metal ions with the highest
permeability for Zn2+ (Zn2+ [ Mg2+ > Mn2+ R Ca2+)
(Monteilh-Zoller et al., 2003) and thus may regulate cytoplasmic
concentrations of these ions. Figure 4A shows that 20 mMTPEN,
a heavy metal chelator, completely blocks RYBP binding to
M7CK. TPEN block is relieved by Zn2+, but not by Ca2+, Mn2+,
or Cu2+. Additional experiments showed that M7CK binding to
proteins containing a zinc finger (RYBP, YY1, and RNF2) is
Zn2+ dependent; binding to proteins not containing a zinc-finger
motif (Ezh2 and INO80) did not require Zn2+ (Figures 4A and 4B).
The critical role of the zinc-finger structure in binding of specific
proteins to M7CK is supported by the finding that the 26-amino-
acid RYBP sequence comprising the zinc-finger domain is suffi-
cient for M7CK binding (Figure 3C). Half-maximal binding of
RYBP, YY1, and RNF2, as well as the purified zinc-finger domain
of RYBP to [Zn2+], was 4 nM (Figure 4C), a concentration that
is 5- to 10-fold higher than resting cytosolic [Zn2+] (Krezel
and Maret, 2006; Li and Maret, 2009; Taki et al., 2004;
Vinkenborg et al., 2009). These levels would easily be reached
by opening of TRPM7 channels, because the driving force for
zinc is inward over the physiological range of voltages (EZn
+80mV). Thus, we set out to determine if TRPM7 Zn2+ conduc-
tion may regulate Zn2+-dependent M7CK targeting to specific
transcription factors.
TRPM7 Affects Cytosolic Zn2+ Concentrations
To determine whether TRPM7 activity affects cytosolic [Zn2+],
we compared [Zn2+] in WT and TrpM7/ mESCs using a stably
expressed protein-encoded zinc sensor, eCALWY-4 (Vinken-
borg et al., 2009). As shown in Figure 5, average cytosolic
[Zn2+] is significantly lower in TrpM7/ than in WT cells (consis-
tent with our previous findings, cytosolic [Mg2+] was normal inCell 157, 1061–10TrpM7/ cells; Figure S5). Importantly,
knockout of TrpM7 resulted in the loss
of the subpopulation of cells with sub-
stantially higher [Zn2+] (Figure 5E). This
suggests that TRPM7-channel activitywas sufficient in these cells to elevate cytosolic zinc to levels
that enabled targeting of M7CK to chromatin-remodeling
complexes.
M7CK Phosphorylate Histones
Because M7CKs are functional kinases (Ryazanova et al., 2004),
we tested whether M7CK binding partners are substrates for
M7CKs. However, extensive experiments failed to show direct
phosphorylation of the verified interactors RYBP, YY1, EZH2,
RING1A, Ruvbl2, and Cul4b by the kinase when the two proteins
were bound (data not shown).
Many chromatin-remodeling complexes covalently modify
core histones by lysine methylation, acetylation, ubiquitination,
or sumoylation (Badeaux and Shi, 2013; Strahl and Allis, 2000).
These modifications are believed to alter chromatin structure
by affecting the recruitment of nonhistone proteins thatmodulate
genomic DNA accessibility for replication, repair, and ‘‘tuning’’
gene expression. Histones are also phosphorylated by several
protein kinases; phosphorylation of specific histone residues
has been associated with transcriptional regulation, apoptosis,
cell-cycle progression, DNA repair, chromosome condensation,
and developmental gene regulation (Baek, 2011; Sawicka and
Seiser, 2012) and may constitute a histone code that underlies
epigenetic inheritance (Cheung et al., 2000a). The observation
that M7CK is a functional protein kinase bound to several chro-
matin-remodeling complexes and located in the nucleus moti-
vated us to explore whether M7CKmodifies the phosphorylation
state of established histone substrates for signaling kinases
(Baek, 2011).
Figure 6A shows that global phosphorylation of histone H3
at serine 10 (H3S10p), serine 28 (H3S28p), and threonine 3
(H3T3p) is dramatically suppressed in TrpM7/ mESCs72, May 22, 2014 ª2014 Elsevier Inc. 1065
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Figure 4. Zinc Dependence of M7CK
Binding to Zinc-Finger Domain-Containing
Proteins
(A) HA-tagged M7CK was coexpressed with
FLAG-tagged interacting proteins in 293T
cells. The cell lysate was split into equal
aliquots and supplemented with 20 mM TPEN
and 50 mM of the indicated ions. M7CK was IP’d
with aHA and the co-IP’d proteins probed with
aFLAG.
(B) FLAG-tagged zinc-finger domain (ZfD)-con-
taining proteins were coexpressed in 293T cells
with HA-tagged M7CK. [Zn2+] was adjusted by
variation of [EGTA] and [ZnSO4]. M7CK-HA was
IP’d with HA-agarose; ZfD protein binding was
detected in the aFLAG WB.
(C) [Zn2+] dependence of M7CK binding to
GST-RYBP ZfD. Purified GST fusion with
RYBP fragment (amino acids 22–47 comprising
the RYBP-ZfD) was combined with purified
M7CK-L in the presence of varying [Zn2+] and pulled down by glutathione agarose (Coomassie-stained gel).
(D) Quantification of M7CK binding shown in (C). Values of integrated pixels of the bound M7CK image were normalized to maximum binding at 10 mM [Zn2+].
Fitted equation and parameters shown.
See also Figure S4.compared to WT cells. In contrast, phosphorylation of threonine
11 (H3T11p) was not affected and served as an intrinsic control.
Differences in histone phosphorylation did not result from cell
clonality, because different clones with the same genotype had
identical levels of histone phosphorylation (Figure 6A). H3S10p
and H3S28p levels were indistinguishable in WT3 cells grown
in normal media or media with an additional 10 mM MgCl2 that
was required for growth of TrpM7/ mESCs (not shown).
To test whether TRPM7 kinase activity underlies changes in
histone phosphorylation, we generated TrpM7/mESCs stably
expressing WT M7CK-L (KO9-CKa) and its kinase-dead mutant
(KO9-CKi; see Figures S2F and S3G and Experimental Proce-
dures for a description of these stable cell lines). Figure 6B
shows that the expression of active kinase rescues changes in
H3 histone phosphorylation, implying that the TRPM7 kinase is
responsible. To our surprise, expression of the inactive M7CK
mutant that was intended to serve as a negative control resulted
in a further 4- to 6-fold decrease in phosphorylation of H3S10
and H3S27 (Figure 6B). This suggests that inactive M7CK acts
as a dominant-negative regulator of another kinase (likely
TRPM6 kinase because of its high sequence homology to
TRPM7).
H3 histone acetylation at lysines 9 and 27 activates multiple
genes (Eberharter and Becker, 2002). Synergistic coupling
between H3S10 and H3S28 phosphorylation and acetylation
of the adjacent K9 and K27 residues has been proposed
(Cheung et al., 2000b; Lau and Cheung, 2011). In agreement
with this finding, TrpM7/ cells also display a substantial
decrease in H3K9 and H3K27 acetylation (Figure 6C). We also
measured a substantial increase of global trimethylation of
H3K9 and H3K27 in TRPM7/ mESCs. It has been surmised
that H3K9me3 and H3K27me3 antibodies poorly recognize
their epitopes when the adjacent residue is phosphorylated
(Duan et al., 2008, Lau and Cheung, 2011). Indeed, when we
pretreated cell lysates with l phosphatase, levels of the
H3K9me3 and H3K27me3 were indistinguishable in WT and1066 Cell 157, 1061–1072, May 22, 2014 ª2014 Elsevier Inc.TRPM7/ mESCs (not shown). The loss of TRPM7 also
resulted in a 6- to 8-fold increase in global phosphorylation of
histone H2AX at serine 139 (gH2AX) that returns to normal
upon expression of active M7CK (Figure 6D). Inactive kinase
expression exhibits the same pattern as the H3 histone: it
enhances the effect of the TRPM7 deletion, dramatically
increasing gH2AX (Figure 6F).
The TRPM7 kinase-dependent modulation of H2AX phos-
phorylation may be mediated by another protein kinase.
Ablation of the TRPM7 kinase increased H2AX phosphorylation,
while active M7CK expression caused a decrease in hyper-
phosphorylated gH2AX. On the other hand, global dephosphor-
ylation of H3S10, H3T11, and H3S28, rescued by M7CK
expression, is consistent with direct phosphorylation of H3 by
M7CK. Because the TRPM7 C-terminal antibody specifically
coimmunoprecipitates H3 histone, but not H2AX histone, from
nuclear extracts of mESCs (Figure 6G), M7CK tightly binds
H3, but not H2AX. In addition, purified M7CK phosphorylated
purified recombinant histones H2, H3, and H4 in vitro (shown
by 33P incorporation; Figure 6H). As shown by western blot
with phosphospecific antibody, purified M7CK phosphorylates
purified H3 histone at S10 and S28 (Figure 6I). These results
imply that M7CK directly phosphorylates selected histone
residues.
M7CK-Dependent Histone Phosphorylation Correlates
with Gene Expression
Histone phosphorylation acts as a critical intermediate step in
chromosome condensation during cell division, DNA-damage
repair, and transcriptional regulation (Baek, 2011; Banerjee and
Chakravarti, 2011; Berger, 2010). Phosphorylation of histone
H2AX onSer139 inmammalian cells is one of the early responses
to double-strand DNA breaks (Xu and Price, 2011), motivating us
to test whether a global increase in gH2AX reflects increased
DNA damage in TrpM7/ cells. Comparison of nuclear expres-
sion of active ATM kinase, a key element in the DNA-damage
Figure 5. Cytosolic [Zn2+] Measured in WT
and TrpM7/ mESCs
(A) Fluorescent image of mESCs stably expressing
the Zn2+ indicator, eCALWY-4.
(B) eCALWY-4 fluorescence recordings from
multiple cells in a single sample.
(C) Calculated cytosolic [Zn2+] shown as
mean ± SEM.
(D) Kolmogorov-Smirnov statistics.
(E) Histogram of [Zn2+] in cell populations for WT3
and TrpM7/ (KO9) mESC 260 cells of each type
were measured in four independent experiments.
See also Figure S5.response (Bekker-Jensen and Mailand, 2010), in WT and
TrpM7/ mESCs (Figure S6A) did not reveal any increase of
DNA double-break foci formation, ruling out increased DNA
damage in TrpM7/ cells. The function of M7CK-dependent
H2AX phosphorylation is unknown.
Global increases of H3S10p and H3S28p in mitotic cells
demonstrate temporal and spatial associations with chro-
mosome condensation (Goto et al., 2002; Wei et al., 1999) and
are sufficiently reliable that H3S10p is widely used as a mitotic
marker. If H310p and H3S28p dephosphorylation in TrpM7/
cells reflects a state of mitotic histone phosphorylation, it would
be detected as a decrease in the proportion of mitotic cells. No
decrease in the percentage of mitotic cell phosphohistone
immunofluorescence (Figure S6B) was observed in counts of
H310p and H3S28p immunofluorescence-positive WT and
TrpM7/ cells. Thus, M7CK phosphorylates histones in inter-
phase. Our results suggest that TRPM7 kinase has no major
effect on the cell cycle, consistent with its lack of effect on
cell-proliferation rates (Figure S2).
Accumulating evidence suggests that local histone phosphor-
ylation on specific residues, particularly H3S10, affects the
expression of specific genes (Baek, 2011; Berger, 2010; Yang
et al., 2012). We next determined if M7CK activity affected
gene expression and if specific gene expression correlated
with M7CK-dependent histone phosphorylation of the affected
genes. We performed microarray analysis for differential gene
expression in WT and TrpM7/ mESCs (Table S3). For further
validation of the microarray data, we selected several genes
with maximally downregulated expression levels in TrpM7/
cells and performed gene expression analysis with quantitative
PCR (qPCR). qPCR comparison of gene expression in mESC
WT, TrpM7/, and TrpM7/ stably expressing M7CK
confirmed the microarray data and demonstrated that gene
downregulation in TrpM7/ cells was rescued byM7CK expres-
sion (Figure 7A). This result argues that gene regulation wasCell 157, 1061–10TRPM7 kinase dependent. Chromatin
immunoprecipitation (ChIP) with antibody
specifically recognizing phosphorylated
H3S10 followed by qPCR with primers
amplifying proximal promoter sequences
of the same genes (ChIP-qPCR) showed
that H3S10p content in promoters of
the genes tested was substantiallydecreased in TrpM7/ cells and that this decrease was rescued
by M7CK expression (Figure 7B). These results suggest that
M7CK-mediated phosphorylation of H3S10 regulates gene
expression.
DISCUSSION
Here, we showed that a portion of TRPM7’s C terminus contain-
ing the functional kinase is cleaved from the channel moiety and
accumulates in the nucleus by binding to transcription factors
composing chromatin-remodeling complexes. In the nucleus,
M7CK phosphorylates histones on specific residues involved
in essential cellular functions such as transcription regulation,
DNA repair, and mitotic chromatin condensation. We also
demonstrated that TRPM7 increases cytosolic free [Zn2+] and
that binding of zinc-finger-containing M7CK interactors is zinc
dependent. These findings suggest a signaling mechanism in
which TRPM7 activation increases cytosolic [Zn2+], that in turn
stimulates binding of M7CK to zinc-dependent transcription
factors. M7CK translocation to the nucleus and subsequent
phosphorylation of nuclear histones changes the chromatin
covalent modification landscape affecting cell differentiation
and embryonic development.
The linkage of protein kinase and channel domains in the
evolution of TRPM channels suggests that these functions are
coupled. We propose that this function is to link zinc entry and
chromatin-modifying functions, in particular through the zinc
dependence of M7CK binding to particular nuclear proteins.
Because zinc concentrations that enable M7CK binding
(EC50 = 4 nM) are only 5- to 10-fold higher then resting intra-
cellular [Zn2+], and because nuclear [Zn2+] closely follows cyto-
solic [Zn2+] (Miranda et al., 2012), it is likely that TRPM7 channel
function precedes initiation of M7CK binding to nuclear proteins.
This is supported by our data that show that cells with inactive
TRPM7 channels have lower cytosolic [Zn2+].72, May 22, 2014 ª2014 Elsevier Inc. 1067
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Figure 6. TRPM7 Kinase-Dependent Global
Histone Phosphorylation and Acetylation
Bar graphs display histone modification data
statistics (mean ± SD, normalized to J1 data) for
three independent experiments.
(A) Global H3S10, H3S28, and H3T3 phosphory-
lation is decreased in TrpM7/ cells. WBs of
mESC histone extracts with specific anti-phos-
phoserine antibodies.
(B) Restoration of histone H3S10 and H3S28
phosphorylation to WT levels by stable expression
of activeM7CK-L in TrpM7/mESCs (KO9+CKa).
Kinase-dead M7CKmutant (KO9+CKi) expression
further decreases H3S10 and H3S28 phosphory-
lation.
(C) Decrease in global H3 histone Lys9 and Lys27
acetylation (H3K9Ac and H3K27Ac) in
Trpm7/mESCs as shown by WB with anti-
acetylated lysine antibodies.
(D and E) WBs and summary of global H2AX
phosphorylation in mESCs.
(F) Attenuation of gH2AX to WT levels by stable
expression of active M7CK-L in TrpM7/mESCs.
Expression of kinase-dead M7CK mutant further
increases H2AX phosphorylation.
(G–I) TRPM7 IP’d from mESCs pulls down H3, but
not H2AX (G). Purified M7CK directly phosphory-
lated purified histones as shown by incorporation
of radioactive phosphate from [g-33P]-ATP (H) and
WBs with specific phosphoserine antibody (I).
See also Figure S6.M7CK formation depends on cell lineage, conditions, and
time, suggesting that specific M7CKs are made in the course
of development and cell differentiation. Whether this mechanism
is based on cell-specific activation/expression of selective
proteases or the presence of specific proteins protecting the
cleavage sites is not known. Interestingly, after truncation, the
portion of TRPM7 containing the channel domain is eliminated.
One potential rationalization for this observation may be that
the kinase-deleted channel stimulates apoptosis (Desai et al.,
2012). That the channel is deleted after kinase cleavage
suggests that the channel is required for kinase function, not
vice versa.
Chromatin-remodeling complexes, and particularly Polycomb
complexes, are transcriptional modifiers that regulate a number
of key processes in cell differentiation via covalent histone
modifications (Fisher and Fisher, 2011; Surface et al., 2010).
M7CKs interact with several transcription factors and nuclear
proteins composing chromatin-modifying complexes. We found
several potential regulatorymechanisms that may tune the spec-
ificity of M7CK binding to particular nuclear complexes. M7CK
binding to different interactors depends on the cleavage site,1068 Cell 157, 1061–1072, May 22, 2014 ª2014 Elsevier Inc.kinase activity, and cytosolic [Zn2+]. The
combination of these factors may provide
specific, cell-context-dependent M7CK
nuclear complex formation. Although
logical to assume that M7CK binding
partners were potential substrates for
the M7 kinase, our in vitro experimentsfailed to show direct M7CK phosphorylation of RYBP, YY1,
EZH2, RING1A, Ruvbl2, or Cul4b when they were in complex
with M7CK. We cannot exclude, however, the possibility that
some other M7CK binding partners are phosphorylated. Never-
theless, M7CK activity is important for nuclear protein binding,
perhaps because M7CK autophosphorylation (Clark et al.,
2008b) is critical for these interactions. In summary, our findings
demonstrate that nuclear protein binding to M7CK increases
nuclear concentrations of M7CK where it phosphorylates his-
tones, indicating that these proteins retain M7CKs in nucleus.
These results strongly suggest that M7CK association with tran-
scription factors may help target M7CK to a specific genomic
location to provide site-specific histone phosphorylation.
Association of M7CK with subunits of PRC2 may seem at
odds with the existing paradigm that PRC2-dependent H3K27
methylation and PRC2 binding to promoters represses transcrip-
tional activity while H3S28 phosphorylation facilitates H3K27
acetylation and transcriptional activation. However, recent
findings indicate that PRC2 (Jacob et al., 2011) and the Ezh2
methyltransferase subunit (Li et al., 2009) can also activate
transcription (Simon and Kingston, 2013). In particular,
Figure 7. M7CK-Dependent H3S10 Histone Phosphorylation in Gene
Promoters Correlates with Gene Expression
(A) M7CK-L expression in TrpM7/ mESC rescues activity of downregulated
genes. Expression of selected genes was quantified with quantitative RT-PCR
(mean ± SD) in WT3, TrpM7/ (KO9), and KO9 stably expressing M7CK-L
(KO9+CKa) mESCs.
(B) H3S10 phosphorylation in promoters of genes affected by TRPM7 deletion
in mESC was attenuated in TrpM7/ (KO9) cells and restored by M7CK
expression (KO9+CKa), as determined by ChIP-qPCR (mean ± SD).H3K27me3 and H3S28p can coexist on the same histone
molecule, and H3K27me3S28 phosphorylation displaces PRC2
from the promoter (Gehani et al., 2010). In a similar scenario,
M7CK binding of PRC2 may target it to a specific site where it
phosphorylates the critical H3S28 and displaces PRC2 to acti-
vate transcription.
We identified two modes of TRPM7-dependent histone
phosphorylation. Phosphorylation of histone H3 residues was
dramatically attenuated when TrpM7 was genetically silenced
but increased when M7CK was restored in TrpM7/ cells. In
conjunction with experiments demonstrating tight binding of
M7CK to H3 histone and in vitro H3 phosphorylation by M7CK,
these data strongly suggest that M7CK directly phosphorylates
H3 histone in vivo. A secondmode of TRPM7-dependent histone
phosphorylation was observed as a substantial increase of
histone H2AX-Ser139 phosphorylation in TrpM7/ cells that
was restored to WT levels by M7CK. This indirect action
suggests that ATM, ATR, and DNA-PK, the protein kinases
known to phosphorylate H2AX (Banerjee and Chakravarti,
2011), may be targets of M7CK.
In summary, the chanzyme TRPM7 is cleaved in a cell- and
time-specific fashion. The cleaved fragment, containing kinasedomain and upstream intrinsically disordered region, binds to
chromatin-remodeling complex proteins in a Zn2+-dependent
fashion. In the nucleus, the kinase phosphorylates histones on
specific residues known to be functionally important for cell dif-
ferentiation and embryonic development.
EXPERIMENTAL PROCEDURES
Full details are provided in Extended Experimental Procedures. Mice were
treated in accordance with guidelines approved by the Boston Children’s
Hospital (BCH) animal care and use committee.
cDNA Constructs
HA- and FLAG-taggedM7CK constructs weremade by cloning PCR-amplified
mouse TrpM7 sequences into modified phCMV3 (Genlantis) and further
subcloning of tagged cDNA into a pPyCAG-IP vector (from Ian Chambers,
University of Edinburgh; Chambers et al., 2003) or the modified bacterial
expression vector pET32 (Novagen) containing an N-terminal fusion of
10xHis-GB1 sequence (from Martin Kurtev, BCH). The NTAP vector, made
in a pcDNA4TO backbone (Invitrogen), contained a sequence encoding
Protein G, a tobacco etch virus protease cleavage site, and streptavidin-bind-
ing peptide, followed by a multiple cloning site, IRES, and EGFP (Bu¨rckstu¨m-
mer et al., 2006). NTAP-M7CK cDNA was made by in-frame subcloning of the
mouse TrpM7 sequence encoding amino acids 1,364–1,863 and C-terminal
HA tag into the NTAP vector.
Derivation and Culture of mESCs
Blastocysts were isolated from TrpM7+/mice (Jin et al., 2008) 3.5 days post-
coitum and cultured on a layer of g-irradiated mouse embryonic fibroblasts
using standard procedures (Bryja et al., 2006) in media containing an addi-
tional 10 mM MgCl2. Single embryonic stem cell colonies were expanded,
genotyped, and transfected with linearized cDNA using nucleofection embry-
onic stem cell solution (protocol A-23; Lonza); stably transfected cells were
selected by antibiotic incubation.
Biochemical Procedures
See Extended Experimental Procedures for details regarding cell extracts for
tandem affinity purification, TRPM7 IP, histone western blots, antibodies,
and buffers. NTAP-M7CK was purified as described in (Bu¨rckstu¨mmer et al.,
2006) in lysis buffer; purified proteins were separated on SDS-PAGE and
proteins digested with trypsin. MALDI-TOF MS and MS/MS peptide analyses
were carried out (Krapivinsky et al., 2011) in the proteomic core facility at BCH.
Purified histones (New England Biolabs) were phosphorylated in vitro
with purified M7CK-L in buffer containing [g-33P]-ATP. GST-RYBP protein
was purified from expressing BL21 bacteria using glutathione Sepharose
(GE Healthcare). M7CK-L mouse TRPM7 protein containing N-terminal
10xHis-GB1 (Hammarstro¨m et al., 2002) and C-terminal HA-epitope tag was
purified from lysates of BL21 bacteria expressing the protein on a cobalt resin
(Talon, Clontech). Samples run on different gels are combined in figures and
aligned against identical molecular weight markers (Figures 1, 2, 4, 6, S1,
S3, and S4) as indicated by blank spaces between lanes.
Fluorescence Microscopy
mESCs stably expressing eCALWY4 were background-corrected 535/480 nm
ratio images for cytosolic [Zn2+]. Free [Zn2+] was calculated for each cell
according to the equation [Zn2+] = Kd [(R  Rmin)/(Rmax  R)] (Dittmer et al.,
2009), where Rmax is the maximum fluorescence ratio obtained with 50 mM
TPEN and Rmin is the minimum fluorescence ratio obtained with 100 mM
ZnCl2 in the presence of the 5 mM Zn
2+ ionophore, pyrithione; KD = 0.63 nM
(Vinkenborg et al., 2009). For cytosolic [Mg2+], mESCs were loaded with
4 mM Mag-Fura/AM (Molecular Probes) at 37C for 30 min in culture medium.
Dye was excited at 350 nm and 380 nm and emission recorded at l > 480 nm.
Free [Mg2+] was calculated according to the equation [Mg2+] = Kd [(R  Rmin)/
(Rmax R)]3 b, where R is the ratio of fluorescence at 350 and 380 nm, Rmax =
1.46 and Rmin = 0.19 are the ratios for Mag-Fura free acid at 350 and 380 nm in
the presence of saturating [Mg2+] and nominally 0 [Mg2+], respectively; b = 4.9,Cell 157, 1061–1072, May 22, 2014 ª2014 Elsevier Inc. 1069
the ratio of fluorescence of Mag-Fura-2 at 380 nm in nominally free and satu-
rating [Mg2+]. Mag-Fura KD for Mg
2+ = 1.5 mM (Raju et al., 1989).
Microarray expression profiling was performed on Illumina MouseWG-6
v2.0 Expression BeadChip arrays at the BCH microarray facility using
GenomeStudio software. These data have been deposited in NCBI’s Gene
Expression Omnibus and are accessible through GEO Series accession
number GSE55578 (http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=
GSE55578).
Chromatin Immunoprecipitation Analysis
Cells were fixed in PBS in 1% paraformaldehyde (7 min, 25C), quenched with
125 mM glycine, and sonicated. Mouse H3S10p (#17-685 Millipore) antibody
and Protein G Dynabeads (Invitrogen) were used for overnight chromatin
immunoprecipitation. The negative ChIP control with normal mouse immuno-
globulin G produced signals <0.01% of the input.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Extended Experimental Procedures, six
figures, and three tables and can be found with this article online at http://
dx.doi.org/10.1016/j.cell.2014.03.046.
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